Number of patients with posttraumatic worry disorder (PTSD) addressed with ketamine in retrospective compared to A chemical derivative of ketamine called esketamine was approved with the FDA in 2019 for use in refractory depression. Taken jointly, the evidence suggests that despite the growing research on maintenance treatment with ketamine and https://lemmye444aqg5.wikimillions.com/user